REGENESIS (CA): A Study of NTx™-265: Human Chorionic Gonadotropin (hCG) and Epoetin Alfa (EPO) in Acute Ischemic Stroke Patients

This study has been terminated.

Study NCT00663416 Information provided by Stem Cell Therapeutics Corp.

First Received: April 18, 2008 Last Updated: August 10, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been terminated.
Estimated Study Completion Date:	January 2009
Estimated Primary Completion Date:	October 2008 (Final data collection date for primary outcome measure)